Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118229928> ?p ?o ?g. }
- W2118229928 endingPage "1968" @default.
- W2118229928 startingPage "1957" @default.
- W2118229928 abstract "To evaluate the efficacy of three hormonal manipulations in the palliation of chemoresistant ovarian cancer, and to analyze the results in the light of other clinical trials.Three sequential phase II trials were performed in patients with refractory epithelial ovarian carcinoma, using high-dose megestrol acetate (800 mg/d for 30 days, then 400 mg/d), high-dose tamoxifen (80 mg/d for 30 days, then 40 mg/d), and aminoglutethimide (1 g/d plus tapering doses of hydrocortisone). Results were compared with those described in the world literature from trials of the same or similar agents.No responses were seen among 30 assessable patients treated with megestrol acetate, and most (but not all) similar trials have reported low response rates. Five responses (17%) were seen among 29 patients treated with tamoxifen. Two responses exceeded 5 years in duration. No responses were seen among 15 patients treated with aminoglutethimide.Antiestrogen therapy may offer the possibility of useful and, occasionally, long-term palliation of refractory epithelial ovarian carcinoma, with little toxicity. There may be a trend toward a dose-response effect, which represents a suitable topic for a future prospective trial." @default.
- W2118229928 created "2016-06-24" @default.
- W2118229928 creator A5003593817 @default.
- W2118229928 creator A5004376520 @default.
- W2118229928 creator A5009170288 @default.
- W2118229928 creator A5016080490 @default.
- W2118229928 creator A5022669637 @default.
- W2118229928 creator A5029342165 @default.
- W2118229928 creator A5042057494 @default.
- W2118229928 creator A5071435454 @default.
- W2118229928 creator A5073311988 @default.
- W2118229928 creator A5073404522 @default.
- W2118229928 date "1993-10-01" @default.
- W2118229928 modified "2023-10-01" @default.
- W2118229928 title "Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program." @default.
- W2118229928 cites W1494386333 @default.
- W2118229928 cites W1534855010 @default.
- W2118229928 cites W1631233922 @default.
- W2118229928 cites W1634658554 @default.
- W2118229928 cites W1873154181 @default.
- W2118229928 cites W1904264146 @default.
- W2118229928 cites W1917258958 @default.
- W2118229928 cites W1930308991 @default.
- W2118229928 cites W1936253731 @default.
- W2118229928 cites W1941817584 @default.
- W2118229928 cites W195846984 @default.
- W2118229928 cites W1965989840 @default.
- W2118229928 cites W1968744769 @default.
- W2118229928 cites W1968937216 @default.
- W2118229928 cites W1969870046 @default.
- W2118229928 cites W1970735557 @default.
- W2118229928 cites W1975673721 @default.
- W2118229928 cites W1978148085 @default.
- W2118229928 cites W1981534406 @default.
- W2118229928 cites W1983840357 @default.
- W2118229928 cites W1986908675 @default.
- W2118229928 cites W1993246929 @default.
- W2118229928 cites W1994439130 @default.
- W2118229928 cites W1997105316 @default.
- W2118229928 cites W1997425090 @default.
- W2118229928 cites W2000258537 @default.
- W2118229928 cites W2001311576 @default.
- W2118229928 cites W2001971211 @default.
- W2118229928 cites W2004371073 @default.
- W2118229928 cites W2005900634 @default.
- W2118229928 cites W2006743903 @default.
- W2118229928 cites W2006860223 @default.
- W2118229928 cites W2006965792 @default.
- W2118229928 cites W2014188407 @default.
- W2118229928 cites W2028082481 @default.
- W2118229928 cites W2036500300 @default.
- W2118229928 cites W2038674422 @default.
- W2118229928 cites W2048584453 @default.
- W2118229928 cites W2052496350 @default.
- W2118229928 cites W2054188738 @default.
- W2118229928 cites W2056434756 @default.
- W2118229928 cites W2060468872 @default.
- W2118229928 cites W2062439823 @default.
- W2118229928 cites W2063154359 @default.
- W2118229928 cites W2066486209 @default.
- W2118229928 cites W2069515526 @default.
- W2118229928 cites W2074596528 @default.
- W2118229928 cites W2077560541 @default.
- W2118229928 cites W2085193421 @default.
- W2118229928 cites W2088499763 @default.
- W2118229928 cites W2092465572 @default.
- W2118229928 cites W2127378759 @default.
- W2118229928 cites W2129609559 @default.
- W2118229928 cites W2132672809 @default.
- W2118229928 cites W2162895067 @default.
- W2118229928 cites W2178925415 @default.
- W2118229928 cites W2179956917 @default.
- W2118229928 cites W2190894843 @default.
- W2118229928 cites W2246231529 @default.
- W2118229928 cites W2259917975 @default.
- W2118229928 cites W2262361826 @default.
- W2118229928 cites W2264660216 @default.
- W2118229928 cites W2276149472 @default.
- W2118229928 cites W2292916867 @default.
- W2118229928 cites W2293895765 @default.
- W2118229928 cites W2297965661 @default.
- W2118229928 cites W2337014572 @default.
- W2118229928 cites W2340242849 @default.
- W2118229928 cites W2404363041 @default.
- W2118229928 cites W2412149865 @default.
- W2118229928 cites W2412593108 @default.
- W2118229928 cites W2416140862 @default.
- W2118229928 cites W2417597934 @default.
- W2118229928 cites W2418048288 @default.
- W2118229928 cites W2418100713 @default.
- W2118229928 cites W2418811816 @default.
- W2118229928 cites W2419184146 @default.
- W2118229928 cites W2419186281 @default.
- W2118229928 cites W2440674496 @default.
- W2118229928 cites W2473930617 @default.
- W2118229928 cites W278341845 @default.
- W2118229928 cites W321374874 @default.
- W2118229928 cites W45574792 @default.